Long Term Adverse Effects
"Long Term Adverse Effects" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Persistent detrimental effects from treatment for a condition. Included are effects from surgery such as POSTOPERATIVE COMPLICATIONS, and from DRUG THERAPY, such as CHEMICALLY INDUCED DISORDERS, or other THERAPEUTICS. Failure to attain a desired outcome from treatment for the condition is not considered an adverse effect.
| Descriptor ID |
D000069451
|
| MeSH Number(s) |
C23.550.543
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Long Term Adverse Effects".
Below are MeSH descriptors whose meaning is more specific than "Long Term Adverse Effects".
This graph shows the total number of publications written about "Long Term Adverse Effects" by people in this website by year, and whether "Long Term Adverse Effects" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Long Term Adverse Effects" by people in Profiles.
-
Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure. Chest. 2021 09; 160(3):831-842.
-
Durability of pneumatic dilation monotherapy in treatment-naive achalasia patients. BMC Gastroenterol. 2019 Nov 11; 19(1):181.
-
Long-term prescription opioid utilization, substance use disorders, and opioid overdoses after adolescent trauma. J Trauma Acute Care Surg. 2019 10; 87(4):836-840.
-
Fluoroquinolone-associated suicide. Eur J Intern Med. 2018 09; 55:e21-e22.
-
Folic acid in pregnancy and mortality from cancer and cardiovascular disease: further follow-up of the Aberdeen folic acid supplementation trial. J Epidemiol Community Health. 2015 Aug; 69(8):789-94.